⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PTHS News
Pelthos Therapeutics Inc.
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
globenewswire.com
PTHS
Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025
globenewswire.com
PTHS
Pelthos Therapeutics Launches Moms Against Molluscum Movement to Unite Families Affected by Molluscum Contagiosum
globenewswire.com
PTHS